Immunogenicity Publication Bias and Its Consequences for Predictive Models: A Call for Transparent Reporting.

CPT Pharmacometrics Syst Pharmacol · 2026 · PMC12896363 · PMID 41603489

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Still, they show a clear trend toward lower maximal ADA incidence in later phases—despite longer trials—likely partly due to early attrition from immunogenicity.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.